VIA
Vident Investment Advisory Portfolio holdings
AUM
$2.9B
1-Year Return
24.65%
This Quarter Return
+8.58%
1 Year Return
+24.65%
3 Year Return
+82.72%
5 Year Return
+113.39%
10 Year Return
–
AUM
$3.29B
AUM Growth
+$322M
(+11%)
Cap. Flow
+$102M
Cap. Flow
% of AUM
3.1%
Top 10 Holdings %
Top 10 Hldgs %
10.67%
Holding
1,133
New
146
Increased
560
Reduced
374
Closed
47
Top Buys
| 1 |
iRhythm Technologies
IRTC
|
+$15.2M |
| 2 |
Apple
AAPL
|
+$9.64M |
| 3 |
AbbVie
ABBV
|
+$8.74M |
| 4 |
Meta Platforms (Facebook)
META
|
+$7.89M |
| 5 |
Comcast
CMCSA
|
+$7.3M |
Top Sells
| 1 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$30.6M |
| 2 |
NVIDIA
NVDA
|
+$10.3M |
| 3 |
Azenta
AZTA
|
+$7.53M |
| 4 |
Rockwell Automation
ROK
|
+$6.2M |
| 5 |
Intuitive Surgical
ISRG
|
+$6.06M |
Sector Composition
| 1 | Technology | 29.71% |
| 2 | Healthcare | 14.09% |
| 3 | Energy | 12.28% |
| 4 | Industrials | 10.32% |
| 5 | Consumer Discretionary | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
Nu Skin
NUS
$570M
| $1.8M | 0.05% |
31,840
-975
| -3% | -$55.2K |
|
452
Sunoco
SUN
$6.99B
| $1.8M | 0.05% |
47,846
+4,224
| +10% | +$159K |
|
453
Instil Bio
TIL
$172M
| $1.8M | 0.05% |
+4,662
| New | +$1.8M |
|
454
Consolidated Edison
ED
$35B
| $1.79M | 0.05% |
24,899
+1,423
| +6% | +$102K |
|
455
Exact Sciences
EXAS
$10.5B
| $1.78M | 0.05% |
14,336
+1,424
| +11% | +$177K |
|
456
Essential Utilities
WTRG
$10.8B
| $1.78M | 0.05% |
38,907
+7,444
| +24% | +$340K |
|
457
PROG Holdings
PRG
$1.4B
| $1.78M | 0.05% |
36,869
-1,128
| -3% | -$54.3K |
|
458
Intercontinental Exchange
ICE
$99.3B
| $1.77M | 0.05% |
14,902
+1,843
| +14% | +$219K |
|
459
CACI
CACI
$10.4B
| $1.76M | 0.05% |
6,909
-213
| -3% | -$54.4K |
|
460
Alnylam Pharmaceuticals
ALNY
$63.2B
| $1.76M | 0.05% |
10,391
-1,206
| -10% | -$204K |
|
461
Morgan Stanley
MS
$243B
| $1.76M | 0.05% |
19,158
+7,132
| +59% | +$654K |
|
462
Iovance Biotherapeutics
IOVA
$858M
| $1.76M | 0.05% |
67,485
+34,477
| +104% | +$897K |
|
463
Goldman Sachs
GS
$231B
| $1.76M | 0.05% |
4,622
+1,583
| +52% | +$601K |
|
|
MXIM
464
DELISTED
Maxim Integrated Products
MXIM
| $1.75M | 0.05% |
16,599
-17,840
| -52% | -$1.88M |
|
|
UBA
465
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $1.74M | 0.05% |
89,955
+2,194
| +2% | +$42.5K |
|
466
Albertsons Companies
ACI
$10.8B
| $1.73M | 0.05% |
87,730
-2,685
| -3% | -$52.8K |
|
467
Arcus Biosciences
RCUS
$1.22B
| $1.72M | 0.05% |
62,765
+7,621
| +14% | +$209K |
|
468
Ford
F
$45.7B
| $1.72M | 0.05% |
115,799
+71,163
| +159% | +$1.06M |
|
469
Host Hotels & Resorts
HST
$12B
| $1.72M | 0.05% |
100,742
+19,550
| +24% | +$334K |
|
470
Nektar Therapeutics
NKTR
$924M
| $1.72M | 0.05% |
6,680
-34
| -0.5% | -$8.75K |
|
471
Unifirst Corp
UNF
$3.24B
| $1.71M | 0.05% |
7,287
-222
| -3% | -$52.1K |
|
472
Sinclair Inc
SBGI
$970M
| $1.71M | 0.05% |
51,344
-1,572
| -3% | -$52.2K |
|
473
Hanover Insurance
THG
$6.36B
| $1.7M | 0.05% |
12,510
-384
| -3% | -$52.1K |
|
474
Atara Biotherapeutics
ATRA
$85.5M
| $1.69M | 0.05% |
4,344
+1,634
| +60% | +$635K |
|
|
BLUE
475
DELISTED
bluebird bio
BLUE
| $1.68M | 0.05% |
4,061
+1,102
| +37% | +$457K |
|